An international survey of the health economics of IVF and ICSI
The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
The health economics of IVF and ICSI involve assessments of utilization, cost, cost-effectiveness and ability to pay. In 48 countries, utilization averaged 289 IVF/ICSI cycles per million of population per annum, ranging from two in Kazachstan, to 1657 in Israel. Higher national utilization of IVF/ICSI was associated with higher quality of health services, as indicated by lower infant mortality rates. IVF and ICSI are scientifically demanding and personnel-intensive, and are therefore expensive procedures. The average cost per IVF/ICSI cycle in 2002 would be US$9547 in the USA, and US$3518 in 25 other countries. Price elasticity estimates suggest that a 10% decrease in IVF/ICSI cost would generate a 30% increase in utilization. The average cost-effectiveness ratios in 2002 would be US$58,394 per live birth in the USA, and US$22,048 in other countries. In three randomized controlled trials, incremental costs per additional live birth with IVF compared with conventional therapy were US$ -26,586, $79,472 and $47,749. The national costs of IVF/ICSI treatment would be US$1.00 per capita in one current model, but the costs to individual couples range from 10% of annual household expenditures in European countries to 25% in Canada and the USA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Health insurance and the demand for medical care: evidence from a randomized experiment.
Manning, W. G., Newhouse, J. P., Duan, N., Keeler, E. B., Leibowitz, A. A., & Marquis, M. S. (1987) · PubMed · Cited by 2,478
Factors that affect outcome of in-vitro fertilisation treatment
Templeton, A., Morris, J. K., & Parslow, W. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05291-9 · Cited by 708
A Controlled Trial of the Effect of a Prepaid Group Practice on Use of Services
Manning, W. G., Leibowitz, A., Goldberg, G. A., Rogers, W. H., & Newhouse, J. P. (1984) · New England Journal of Medicine · doi:10.1056/nejm198406073102305 · Cited by 572
Statistical Abstract of the United States, 1979.
Clogg, C. C., & Census, U. S. B. O. T. (1980) · Journal of the American Statistical Association · doi:10.2307/2287201 · Cited by 412
Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization
Templeton, A., & Morris, J. K. (1998) · New England Journal of Medicine · doi:10.1056/nejm199808273390901 · Cited by 391
Ryan, M. (1999) · Social Science & Medicine · doi:10.1016/s0277-9536(98)00374-8 · Cited by 342
Social determinants of human reproduction
The ESHRE Capri Workshop Group (2001) · Human Reproduction · doi:10.1093/humrep/16.7.1518 · Cited by 160
Evaluation of the relative cost-effectiveness of treatments for infertility in the UK
Philips, Z., Barraza-Llorens, M., & Posnett, J. (2000) · Human Reproduction · doi:10.1093/humrep/15.1.95 · Cited by 146
Use of infertility services in the United States.
Wilcox, L. S., & Mosher, W. D. (1993) · PubMed · Cited by 132
An estimate of the cost of in vitro fertilization services in the United States in 1995
Collins, J. A., Bustillo, M., Visscher, R. D., & Lawrence, L. D. (1995) · Fertility and Sterility · doi:10.1016/s0015-0282(16)57789-9 · Cited by 122
Self-citation
Cited by
Inhorn, M. C., & Patrizio, P. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv016 · Cited by 1,926
“These were mostly the affluent, Western nations accounting for 91% of the world’s gross domestic product (Collins, 2002).”
BackgroundInfluentialThe Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Macklon, N. S., Stouffer, R. L., Giudice, L. C., & Fauser, B. C. J. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0015 · Cited by 562
Zegers-Hochschild, F., Mansour, R., Ishihara, O., Adamson, G. D., de Mouzon, J., Nygren, K. G., & Sullivan, E. A. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.10.005 · Cited by 540
The economic impact of assisted reproductive technology: a review of selected developed countries
Chambers, G. M., Sullivan, E. A., Ishihara, O., Chapman, M. G., & Adamson, G. D. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.04.029 · Cited by 438
Sullivan, E. A., Zegers-Hochschild, F., Mansour, R., Ishihara, O., de Mouzon, J., Nygren, K. G., & Adamson, G. D. (2013) · Human Reproduction · doi:10.1093/humrep/det036 · Cited by 414
Multiple birth resulting from ovarian stimulation for subfertility treatment
Fauser, B. C., Devroey, P., & Macklon, N. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66478-1 · Cited by 407
A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial
Heijnen, E. M., Eijkemans, M. J., De Klerk, C., Polinder, S., Beckers, N. G., Klinkert, E. R., Broekmans, F. J., Passchier, J., Te Velde, E. R., Macklon, N. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60360-2 · Cited by 349
International disparities in access to infertility services
Nachtigall, R. D. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.08.066 · Cited by 347
Some of the Factors Involved in Male Infertility: A Prospective Review
Babakhanzadeh, E., Nazari, M., Ghasemifar, S., & Khodadadian, A. (2020) · International Journal of General Medicine · doi:10.2147/ijgm.s241099 · Cited by 314
Socioeconomic and racial disparities among infertility patients seeking care
Jain, T. (2006) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.07.1338 · Cited by 304
Albuz, F. K., Sasseville, M., Lane, M., Armstrong, D. T., Thompson, J. G., & Gilchrist, R. B. (2010) · Human Reproduction · doi:10.1093/humrep/deq246 · Cited by 284
Twin Peaks: more twinning in humans than ever before
Monden, C., Pison, G., & Smits, J. (2021) · Human Reproduction · doi:10.1093/humrep/deab029 · Cited by 234
Disparities in access to infertility services in a state with mandated insurance coverage
Jain, T., & Hornstein, M. D. (2005) · Fertility and Sterility · doi:10.1016/j.fertnstert.2005.01.118 · Cited by 210
The costs and consequences of assisted reproductive technology: an economic perspective
Connolly, M. P., Hoorens, S., Chambers, G. M., & on behalf of the ESHRE Reproduction and Society Task Force (2010) · Human Reproduction Update · doi:10.1093/humupd/dmq013 · Cited by 197
De Geyter, C., Wyns, C., Calhaz-Jorge, C., de Mouzon, J., Ferraretti, A. P., Kupka, M., Nyboe Andersen, A., Nygren, K. G., & Goossens, V (2020) · Human Reproduction · doi:10.1093/humrep/deaa250 · Cited by 195
“The high impact of ART in Europe together with a level of utilization reaching 1410 treatments per 1 million inhabitants in countries with complete coverage (from a medical point of view the optimal goal being at least 1500 treatments per 1 million inhabitants, ESHRE Capri Workshop Group, 2001; Collins 2002) resulted…”
InfluentialUniversal coverage of IVF pays off
Velez, M. P., Connolly, M. P., Kadoch, I. J., Phillips, S., & Bissonnette, F. (2014) · Human Reproduction · doi:10.1093/humrep/deu067 · Cited by 97
Ziebe, S., Devroey, P., & on behalf of the State of the ART 2007 Workshop Group (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn038 · Cited by 77
The effect of in vitro fertilization on birth rates in western countries
Habbema, J. D. F., Eijkemans, M. J. C., Nargund, G., Beets, G., Leridon, H., & te Velde, E. R. (2009) · Human Reproduction · doi:10.1093/humrep/dep004 · Cited by 78
“The medical consequences of multiple births have a greater impact on healthcare costs than the IVF treatment itself (Collins, 2002; Evers, 2002).”
BackgroundAvailability, effectiveness and safety of ART in sub-Saharan Africa: a systematic review
Botha, B., Shamley, D., & Dyer, S. (2018) · Human Reproduction Open · doi:10.1093/hropen/hoy003 · Cited by 41
“One thousand five hundred cycles per million population per year are required to meet the need for ART, but in 2010 the regional mean for sub-Saharan Africa – albeit based on only three countries – was 87 cycles/million (Collins, 2002; Dyer et al., 2016).”
BackgroundEthical issues of infertility treatment in developing countries
Pennings, G. (2008) · ESHRE Monographs · doi:10.1093/humrep/den142 · Cited by 38
The impact of religion and culture on medically assisted reproduction in the Middle East and Europe
Serour, G. I., & Serour, A. G. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.06.002 · Cited by 36
Svensson, A., Connolly, M., Gallo, F., & Hägglund, L. (2008) · Scandinavian Journal of Public Health · doi:10.1177/1403494808095086 · Cited by 21
Metadata
- Authors
- Collins, J. A.
- Venue
- Human Reproduction Update
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-05-01
- Volume
- 8
- Issue
- 3
- Pages
- 265-277
- ISSN
- 1355-4786 (ISSN-L)
- 1460-2369
- OpenAlex
- W2117001305
- Cited by
- 311
- References
- 28
- FWCI
- 7.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.